Diabetes – Janumet Tablets 50/500 Mg

Diabetes – Janumet Tablets 50/500 Mg

Diabetes – Janumet Tablets 50/500 Mg is a combination oral anti-diabetic medication used for the management of type 2 diabetes mellitus. It contains sitagliptin (a DPP-4 inhibitor) and metformin (a biguanide), providing dual action to effectively control blood sugar levels. This combination improves insulin secretion and reduces glucose production in the liver, making it highly effective for patients who do not achieve adequate control with a single medication. In diabetes management, individual drugs like Sitagliptin Tablets 50 Mg and oral agents such as Metformin Tablets 500 Mg are also used depending on patient needs.

Mechanism of Action

Dual Drug Action

• Sitagliptin increases incretin hormones, enhancing insulin release.
• Metformin reduces glucose production and improves insulin sensitivity.

Better Glycemic Control

This combination helps control both fasting and post-meal blood sugar levels. For clinical insights, refer to American Diabetes Association (ADA) and for safety guidance, consult Mayo Clinic – Sitagliptin and Metformin Information.

Medical Uses

Diabetes – Janumet Tablets 50/500 Mg is used for:

• Type 2 diabetes mellitus
• Blood sugar control
• Combination therapy for improved glycemic management

It is commonly prescribed when single-drug therapy is not sufficient.

Dosage and Administration

Janumet Tablets 50/500 Mg is usually taken with meals to reduce gastrointestinal side effects, as directed by a healthcare provider. The dosage is adjusted based on blood sugar levels and patient response. In clinical practice, Sitagliptin Tablets 50 Mg or Metformin Tablets 500 Mg may be used individually depending on treatment requirements.

Clinical Effectiveness

Clinical studies show that this combination effectively lowers blood sugar levels, improves insulin function, and reduces the risk of diabetes-related complications when used consistently.

Safety and Side Effects

Common Side Effects

• Nausea
• Diarrhea
• Headache

Serious Risks

• Lactic acidosis (rare)
• Pancreatitis (rare)

Regular monitoring is recommended. For more details, refer to Mayo Clinic – Sitagliptin and Metformin Information.

Contraindications and Precautions

Janumet Tablets 50/500 Mg should not be used in:

• Patients with severe kidney disease
• Individuals with metabolic acidosis
• Patients with a history of pancreatitis (use with caution)

Consult a healthcare provider before use.

Drug Interactions

This medication may interact with other antidiabetic drugs, increasing the risk of hypoglycemia. Patients should inform their healthcare provider about all medicines they are taking. For further reading, refer to American Diabetes Association (ADA).

FAQs